Provided by Tiger Trade Technology Pte. Ltd.

Soleno Therapeutics

33.39
-0.3650-1.08%
Post-market: 33.390.00000.00%19:45 EDT
Volume:1.66M
Turnover:56.50M
Market Cap:1.72B
PE:85.62
High:34.89
Open:33.87
Low:33.25
Close:33.76
52wk High:90.32
52wk Low:32.63
Shares:51.62M
Float Shares:44.87M
Volume Ratio:0.89
T/O Rate:3.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3900
EPS(LYR):0.3900
ROE:6.01%
ROA:2.09%
PB:3.83
PE(LYR):85.62

Loading ...

How Investors May Respond To Soleno Therapeutics (SLNO) Legal Scrutiny After Accelerated Buyback

Simply Wall St.
·
Nov 18, 2025

Soleno Therapeutics Files Initial Beneficial Ownership Statement for Chief Development Officer Manher Joshi

Reuters
·
Nov 13, 2025

Soleno Therapeutics Shares Rise 5.5% After $100 Million Share Repurchase Program

THOMSON REUTERS
·
Nov 11, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Nebius, Estee Lauder, Soleno

Reuters
·
Nov 11, 2025

Soleno Therapeutics Shares Rise 8.4% Premarket After Co Announces Entry Into $100 Mln Accelerated Share Repurchase Agreement

THOMSON REUTERS
·
Nov 11, 2025

Soleno Therapeutics Signs $100 Million Accelerated Share Repurchase Deal; Shares Up Pre-Bell

MT Newswires Live
·
Nov 11, 2025

Stock Track | Soleno Therapeutics Soars 5.70% Pre-market on $100 Million Share Repurchase Agreement

Stock Track
·
Nov 11, 2025

Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement

THOMSON REUTERS
·
Nov 11, 2025

Stock Track | Soleno Therapeutics Plummets 5.44% Pre-Market on New Financial Risk Disclosure

Stock Track
·
Nov 06, 2025

Soleno Therapeutics’ Financial Challenges: Navigating Risks in VYKAT XR Commercialization

TIPRANKS
·
Nov 06, 2025

Soleno Therapeutics falls -29.0%

TIPRANKS
·
Nov 06, 2025

Soleno Therapeutics Down Over 29%, on Pace for Largest Percent Decrease Since March 2021 -- Data Talk

Dow Jones
·
Nov 06, 2025

Cantor Fitzgerald Sticks to Their Buy Rating for Soleno Therapeutics (SLNO)

TIPRANKS
·
Nov 05, 2025

Stifel Nicolaus Sticks to Their Buy Rating for Soleno Therapeutics (SLNO)

TIPRANKS
·
Nov 05, 2025

Soleno Therapeutics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Nov 05, 2025

Stock Track | Soleno Therapeutics Plummets 26.69% Despite Strong Q3 Earnings, Puzzling Investors

Stock Track
·
Nov 05, 2025

Stock Track | Soleno Therapeutics Plunges 21% Pre-Market Despite Strong Q3 Earnings Beat

Stock Track
·
Nov 05, 2025

Stock Track | Soleno Therapeutics Plummets 21.39% in Pre-market Despite Strong Q3 Earnings, Puzzling Investors

Stock Track
·
Nov 05, 2025

Soleno Therapeutics: Strong Sales Growth and Profitability Drive Buy Rating

TIPRANKS
·
Nov 05, 2025

Stock Track | Soleno Therapeutics Plunges 20% Despite Strong Q3 Earnings, Beating Expectations

Stock Track
·
Nov 05, 2025